Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
NVCT
#3038
Nuvectis Pharma, Inc. Common Stock
8.8
6
-0.78%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.78%
Monthly Change
+0.68%
6 month change
+32.24%
Cambio anual
+27.85%
Cierres anteriores
8.9
3
Open
8.8
6
Bid
Ask
Low
8.8
6
High
8.8
6
Volumen
17
Markets
Acciones
Atención Sanitaria
NVCT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
19.32 M
23.39 M
23.63 M
25.46 M
25.61 M
26.49 M
—
Valuation ratios
Enterprise value
104.33 M
108.05 M
201.01 M
163.36 M
118.8 M
168.41 M
651.59 M
Price to earnings ratio
-5.42
-4.87
-8.65
-6.38
-4.39
-5.72
-25.14
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
7.59
7.56
14.55
11.48
8.49
10.29
44.81
Price to book ratio
2.09
9.53
3.26
2.45
1.74
8.94
16.39
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.24
0.34
0.18
0.23
0.21
0.23
0.85
Return on equity %
0.38
0.64
0.25
0.38
0.31
0.4
1.34
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.74
2.09
3.28
2.66
3.07
2.38
11.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.14
0.21
0.16
0.2
0.18
0.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1
1.08
1.5
1.25
1.56
1.45
5.76
Net current asset value per share
1
1.09
1.51
1.26
1.57
1.45
5.8
Tangible book value per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Working capital per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Book value per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Noticias
Nuvectis initiates phase 1b trial combining NXP900 with osimertinib
ヌベクティス・ファーマの株式評価、H.C.ウェインライトがBuy評価を再確認
Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright
カプラン氏、ヌベクティス・ファーマ(NVCT)株を64,240ドル分購入
ヌベクティス・ファーマの会長ベンツァー氏、2万8,600ドル相当の株式を購入
ヌベクティス・ファーマの取締役サンチェス氏、NVCTの株式を7.5万ドル分購入
H.C. ワインライト、ヌベクティス・ファーマの株式に対する買い推奨を10ドルのターゲットで維持
H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target
Nuvectis Pharma adds former Intra-Cellular exec to board of directors
Nuvectis initiates phase 1b program for cancer drug NXP900
Nuvectis (NVCT) Q2 Loss Widens 43%
Nuvectis Pharma stock price target lowered to $10 at H.C. Wainwright